• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    大

    大分県立病院

    Oita Prefectural Hospital
    EST. 1972
    677论文总数
    1.2万引用总数

    论文量&引用量时间轴

    机构学者

    论文(677)

    年份
    起
    –
    止
    排序
    1Five-year Interim Analysis of J-SKI: an Observational Study of TKI Discontinuation in Patients with CML in Japan
    Naoto Takahashi,Shinya Kimura,Eri Matsuki,Takaaki Ono,Noriko Doki,Masaki Iino,Masashi Sawa,Yoshio Saburi,Kazunori Murai,Katsumichi Fujimaki,Shingo Kurahashi,Noriyoshi Iriyama,

    Treatment-free remission (TFR) is an emerging goal for patients with chronic myeloid leukemia (CML) treated with tyrosine kinase inhibitors (TKI). However, long-term TFR durability in real-world settings remains understudied. The J-SKI study, a large observational study, was conducted to evaluate long-term TFR outcomes in Japanese patients with CML. This interim analysis included 795 eligible patients from the prospective (n = 283) and retrospective (n = 512) cohorts. With a median follow-up of 32 months (range 0.8–168) after TKI discontinuation, the 5-year TFR rate was 65.2

    2026International Journal of Hematology(2026)引用:2
    引用
    AI阅读
    加入学术空间
    2Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission after Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study
    Tatsuro Jo,Yoshio Saburi,Taro Masunari, Kazuhiro Noguchi, Takahiro Sakai,Jun Taguchi,Eiichi Ohtsuka,Nobuo Sezaki, Ritsuko Kubota-Koketsu,Toru Kiguchi

    We prospectively evaluated whether cytotoxic T-lymphocyte (CTL) activation and T-cell receptor (TCR) Vβ clonality predict treatment-free remission (TFR) after tyrosine kinase inhibitor (TKI) cessation in chronic-phase chronic myeloid leukemia (CML). Forty-five patients with sustained deep molecular response (DMR) were enrolled (On-TKI, n = 38; Off-TKI, n = 7) and underwent one-year immuno-monitoring from consent. The primary endpoint was 12-month TFR, defined as retention of MR4. Overall, 32/45 patients (71%) maintained TFR at 12 months. Longer TKI exposure and stable DMR were associated with TFR; notably, patients fulfilling "≥7 years of TKI plus ≥1 year of DMR" and exhibiting CTL activation features-CD8 > CD4, memory > effector, and/or highly activated CTL clones on TCR Vβ repertoire-showed the highest likelihood of durable TFR. By contrast, NK cells, effector Tregs, and G-/M-MDSCs did not discriminate TFR status in this cohort. Although antigen specificity against CML stem cells was not directly tested, the memory-dominant CTL phenotype is consistent with immune control after antigen reduction. These findings suggest that a simple, clinically accessible strategy based on flow cytometric CTL profiling and TCR Vβ clonality may help inform TKI discontinuation decisions in CML. External validation is warranted to confirm transportability and refine clinical thresholds.

    2026International journal of molecular sciences(2026)引用:2
    引用
    AI阅读
    加入学术空间
    3Intraoperative Fluoroscopic Evaluation of Trochanteric Fracture Reduction Using a Novel Anteromedial Cortex View: A Multicenter Prospective Observational Study.
    Shozo Kanezaki,Masashi Miyazaki, Yoshiki Matsumoto, Tomonori Tabata, Ryuzo Kodera, Tsutomu Higashi,Akihiro Hino, Masahiro Kawagishi,Nobuhiro Kaku

    BACKGROUND:Accurate intraoperative assessment of fracture reduction is essential in trochanteric fracture surgery to prevent mechanical failure. Although restoration of anteromedial cortical support, particularly in the sagittal plane, has been recognized as a critical factor, standard lateral views may fail to detect malreduction because the shadow of the greater trochanter overlaps and obscures the anteromedial cortical line. This study aimed to evaluate the clinical utility of a novel intraoperative anteromedial cortex (AMC) view for assessing fracture reduction. METHODS:This prospective multicenter observational study included 135 trochanteric fractures (AO/OTA 31A1.2, 31A1.3, and 31A2) surgically treated between June 2022 and December 2023. In addition to standard AP and lateral fluoroscopic views, an AMC view was obtained intraoperatively. Reduction on the lateral and AMC views was categorized as anterior malreduction, anatomic reduction, or posterior malreduction. The primary outcome was the concordance rate between the lateral and AMC views. RESULTS:Discordances between lateral and AMC views were observed in 26 of 135 cases (19.3%). Notably, among fractures classified as anatomic reduction on the lateral view, 12 cases (19.4%) were reclassified as anterior malreduction on the AMC view, representing "hidden" anterior malreduction. In 7 of these 12 cases (5.2% of the total cohort), the AMC view findings directly led to a change in the surgical strategy, requiring direct reduction through a small incision. CONCLUSIONS:Approximately one-fifth of trochanteric fractures showed inconsistent reduction patterns between the standard lateral the AMC views. The AMC view provides a more precise intraoperative assessment of the anteromedial cortex and is particularly effective in identifying hidden anterior malreduction that may be overlooked on standard fluoroscopy.

    2026Injury(2026)引用:1
    引用
    AI阅读
    加入学术空间
    4A Case of Parkinsonism Possibly Associated with Long-Term Methamphetamine Use
    Yasuhiro Aso,Teruaki Masuda, Kaori Sumi, Katsunori Takahata,Noriyuki Kimura
    2026Rinsho Shinkeigaku(2026)
    引用
    AI阅读
    加入学术空间
    5Executive Summary of the Japanese Clinical Practice Guidelines for Tuberous Sclerosis Complex-Associated Epilepsy 2025
    Tohru Okanishi, Satoru Sakuma,Kenjiro Kikuchi,Susumu Ito, Kazuo Okanari,Ayataka Fujimoto,Ryoko Honda,Masashi Mizuguchi

    Purpose Tuberous sclerosis complex (TSC)-associated epilepsy often involves focal epilepsy, infantile epileptic spasms syndrome (IESS), and drug-resistant epilepsy (DRE). This article presents an executive summary of the Japanese Clinical Practice Guidelines for Tuberous Sclerosis Complex-associated Epilepsy 2025, developed to support the diagnosis, evaluation, and treatment of epilepsy in patients with TSC in Japan. Methods The guideline was developed by the Japanese Society of Child Neurology and the Japanese Society of Tuberous Sclerosis Complex in accordance with the Minds Manual for Guideline Development 2020. A clinical algorithm reflecting Japanese practices was created, and background questions (BQs) and one clinical question (CQ) were formulated. Evidence was collected through searches of PubMed and Ichushi-Web for articles published between 1983 and May 2021. For the CQ, a systematic review was conducted, and the recommendation was determined using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) grid method. Results The guideline covers the pathway from diagnosis and evaluation to treatment, considering TSC diagnosed before and after epilepsy onset. Based on neuroimaging and EEG-based evaluations, epilepsy is broadly classified into focal epilepsy and IESS, including West syndrome. The BQs summarize treatment strategies for focal epilepsy and IESS, and address the definition, characteristics, and treatment options for DRE, including epilepsy surgery, mammalian target of rapamycin (mTOR) inhibitor therapy, vagus nerve stimulation, and dietary therapy. The only CQ addressed adjunctive mTOR inhibitor therapy for DRE. This therapy was conditionally recommended with low certainty of evidence. Conclusions This guideline provides a practical framework for TSC-associated epilepsy in Japan and shows how current evidence and expert recommendations can be applied to the Japanese healthcare system.

    2026Brain & development(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 677 篇论文

    合作机构(100)

    大分大学合作论文 117
    九州大学合作论文 114
    长崎大学合作论文 47
    福冈大学合作论文 41
    Hamanomachi Hospital合作论文 40
    宮崎県立病院合作论文 38
    九州大学医院合作论文 37
    Sasebo City General Hospital合作论文 33
    Nagasaki University Hospital合作论文 33
    鹿儿岛大学合作论文 31

    机构统计